183 related articles for article (PubMed ID: 23488987)
1. Enzymatic conversion of 6-nitroquinoline to the fluorophore 6-aminoquinoline selectively under hypoxic conditions.
Rajapakse A; Linder C; Morrison RD; Sarkar U; Leigh ND; Barnes CL; Daniels JS; Gates KS
Chem Res Toxicol; 2013 Apr; 26(4):555-63. PubMed ID: 23488987
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-selective, enzymatic conversion of 6-nitroquinoline into a fluorescent helicene: pyrido[3,2-f]quinolino[6,5-c]cinnoline 3-oxide.
Rajapakse A; Gates KS
J Org Chem; 2012 Apr; 77(7):3531-7. PubMed ID: 22417220
[TBL] [Abstract][Full Text] [Related]
3. Metabolic and radiolytic reduction of 4-alkylamino-5-nitroquinoline bioreductive drugs. Relationship to hypoxia-selective cytotoxicity.
Siim BG; Atwell GJ; Wilson WR
Biochem Pharmacol; 1994 Oct; 48(8):1593-604. PubMed ID: 7980625
[TBL] [Abstract][Full Text] [Related]
4. Loss of fluorescence by anthracycline antibiotics: effects of xanthine oxidase and identification of the nonfluorescent metabolites.
Dodion P; Bernstein AL; Fox BM; Bachur NR
Cancer Res; 1987 Feb; 47(4):1036-9. PubMed ID: 3467841
[TBL] [Abstract][Full Text] [Related]
5. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cells.
Seow HA; Penketh PG; Shyam K; Rockwell S; Sartorelli AC
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9282-7. PubMed ID: 15964988
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugs.
Siim BG; Atwell GJ; Anderson RF; Wardman P; Pullen SM; Wilson WR; Denny WA
J Med Chem; 1997 Apr; 40(9):1381-90. PubMed ID: 9135035
[TBL] [Abstract][Full Text] [Related]
7. FSL-61 is a 6-nitroquinolone fluorogenic probe for one-electron reductases in hypoxic cells.
Su J; Guise CP; Wilson WR
Biochem J; 2013 May; 452(1):79-86. PubMed ID: 23480813
[TBL] [Abstract][Full Text] [Related]
8. Role of the nitro functionality in the DNA binding of 3-nitro-10-methylbenzothiazolo[3,2-a]quinolinium chloride.
Colón IG; González FA; Cordero M; Zayas B; Velez C; Cox O; Kumar A; Alegría AE
Chem Res Toxicol; 2008 Sep; 21(9):1706-15. PubMed ID: 18759504
[TBL] [Abstract][Full Text] [Related]
9. Reductive Activity and Mechanism of Hypoxia- Targeted AGT Inhibitors: An Experimental and Theoretical Investigation.
Xiao W; Sun G; Fan T; Liu J; Zhang N; Zhao L; Zhong R
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847200
[TBL] [Abstract][Full Text] [Related]
10. The two faces of aldehyde oxidase: Oxidative and reductive transformations of 5-nitroquinoline.
Paragas EM; Humphreys SC; Min J; Joswig-Jones CA; Jones JP
Biochem Pharmacol; 2017 Dec; 145():210-217. PubMed ID: 28888950
[TBL] [Abstract][Full Text] [Related]
11. Nitrite reductase activity of rat and human xanthine oxidase, xanthine dehydrogenase, and aldehyde oxidase: evaluation of their contribution to NO formation in vivo.
Maia LB; Pereira V; Mira L; Moura JJ
Biochemistry; 2015 Jan; 54(3):685-710. PubMed ID: 25537183
[TBL] [Abstract][Full Text] [Related]
12. 3-amino-1,2,4-benzotriazine 4-oxide: characterization of a new metabolite arising from bioreductive processing of the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).
Fuchs T; Chowdhury G; Barnes CL; Gates KS
J Org Chem; 2001 Jan; 66(1):107-14. PubMed ID: 11429885
[TBL] [Abstract][Full Text] [Related]
13. Does DNA targeting affect the cytotoxicity and cell uptake of basic nitroquinoline bioreductive drugs?
Siim BG; Denny WA; Wilson WR
Int J Radiat Oncol Biol Phys; 1994 May; 29(2):311-5. PubMed ID: 8195025
[TBL] [Abstract][Full Text] [Related]
14. Reductive chemistry of the novel hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
Palmer BD; van Zijl P; Denny WA; Wilson WR
J Med Chem; 1995 Mar; 38(7):1229-41. PubMed ID: 7707325
[TBL] [Abstract][Full Text] [Related]
15. N-Hydroxyguanidine compound 1-(3,4-dimethoxy- 2-chlorobenzylideneamino)-3-hydroxyguanidine inhibits the xanthine oxidase mediated generation of superoxide radical.
Dambrova M; Baumane L; Kiuru A; Kalvinsh I; Wikberg JE
Arch Biochem Biophys; 2000 May; 377(1):101-8. PubMed ID: 10775447
[TBL] [Abstract][Full Text] [Related]
16. The kinetics of 1-nitropyrene and 3-nitrofluoranthene metabolism using bovine liver xanthine oxidase.
Bauer SL; Howard PC
Cancer Lett; 1990 Oct; 54(1-2):37-42. PubMed ID: 2208087
[TBL] [Abstract][Full Text] [Related]
17. Release of xanthine oxidase to the systemic circulation during resuscitation from severe hypoxemia in newborn pigs.
Rootwelt T; Almaas R; Oyasaeter S; Moen A; Saugstad OD
Acta Paediatr; 1995 May; 84(5):507-11. PubMed ID: 7633144
[TBL] [Abstract][Full Text] [Related]
18. Minimal role of xanthine oxidase and oxygen free radicals in rat renal tubular reoxygenation injury.
Doctor RB; Mandel LJ
J Am Soc Nephrol; 1991 Jan; 1(7):959-69. PubMed ID: 1883966
[TBL] [Abstract][Full Text] [Related]
19. Effects of hypoxia and ethanol on xanthine oxidase of isolated rat hepatocytes: conversion from D to O form and leakage from cells.
Battelli MG; Abbondanza A; Stirpe F
Chem Biol Interact; 1992 Jun; 83(1):73-84. PubMed ID: 1643670
[TBL] [Abstract][Full Text] [Related]
20. Nitroaryl compounds as potential fluorescent probes for hypoxia. I. Chemical criteria and constraints.
Wardman P; Clarke ED; Hodgkiss RJ; Middleton RW; Parrick J; Stratford MR
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1347-51. PubMed ID: 6547939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
